PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Pipeline portfolio • Pipeline analysis PART 06: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 07: Market segmentation by product • Cell therapy • Ethical issues of stem cell research • Global cell therapy market • Tissue scaffold • Global tissue scaffold market • Gene therapy • Gene therapy market in Europe PART 08: Market segmentation by application • Dermatology • Musculoskeletal • Ocular • Cardiovascular PART 09: Geographical segmentation • Regenerative medicine market in Americas • Regenerative medicine market in EMEA • Regenerative medicine market in APAC PART 10: Market drivers • Increased prevalence of chronic diseases • Funding by governments in regenerative medicine • Increased focus on cell therapy products • Technological innovations PART 11: Impact of drivers PART 12: Market challenges • Stringent regulatory standards impeding product approvals • Ethical challenges in stem cell research • High cost and failure rate in clinical trials PART 13: Impact of drivers and challenges PART 14: Market trends • Increase in strategic alliances • Increased number of regenerative medicine in the pipeline • Gene therapy trending toward geographic expansion PART 15: Vendor landscape • Competitive scenario • Acelity • Medtronic • MiMedx Group • Organogenesis • UniQure • Zimmer Biomet • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Overview of key sectors involved in regenerative medicine Exhibit 03: Key sectors in regenerative medicine 2015 Exhibit 04: SBIR and STTR programs Exhibit 05: Clinical trials 2014 Exhibit 06: Number of clinical trials and products in regenerative medicine market 2014 Exhibit 07: Pipeline of regenerative medicines for CVDs Exhibit 08: Pipeline of regenerative medicines for central nervous system, orthopedic, and ocular disorders Exhibit 09: Pipeline of regenerative medicines for dermatology and diabetes Exhibit 10: Pipeline of regenerative medicines for oncology Exhibit 11: Global regenerative medicine market 2015-2020 ($ billions) Exhibit 12: Five forces analysis Exhibit 13: Global regenerative medicine market by product Exhibit 14: Global regenerative medicine market by product 2015 Exhibit 15: Cell therapy: Overview Exhibit 16: Ethical issues faced in different cell therapy research category Exhibit 17: Stem cell research policies in emerging countries in Americas Exhibit 18: Stem cell research policies in EMEA Exhibit 19: Stem cell research policies in APAC Exhibit 20: Key cell therapy products marketed in the US Exhibit 21: Key cell therapy products marketed in EMEA Exhibit 22: Key marketed cell therapy products in APAC Exhibit 23: Opportunity analysis of cell therapy in global regenerative medicine market Exhibit 25: Collaborations for R&D of tissue scaffold Exhibit 26: Opportunity analysis of tissue scaffold in regenerative medicine market Exhibit 27: Global tissue scaffold market 2015-2020 ($ billions) Exhibit 28: Recent M&A in tissue scaffold market Exhibit 29: Gene therapy products in Europe Exhibit 30: Opportunity analysis of gene therapy in global regenerative medicine market Exhibit 31: Gene therapy market in Europe 2015-2020 ($ billions) Exhibit 32: European Commission support in gene transfer and gene therapy projects Exhibit 33: Global regenerative medicine market by application Exhibit 34: Global regenerative medicine market by application 2015 Exhibit 35: Overview of dermatology segment in global regenerative medicine market Exhibit 36: Pipeline of regenerative medicine for dermatology Exhibit 37: Overview of musculoskeletal segment in global regenerative medicine market Exhibit 38: Overview of ocular segment in global regenerative medicine market Exhibit 39: Overview of cardiovascular segment in global regenerative medicine market Exhibit 40: Global regenerative medicine market by geography 2015 Exhibit 41: Global regenerative medicine market by geography 2020 Exhibit 42: Funding by federal agencies for R&D of regenerative medicine 2014 ($ millions) Exhibit 43: Regenerative medicine market in Americas 2015-2020 ($ billions) Exhibit 44: Distribution of 45 cell therapy vendors in Europe 2011 Exhibit 45: Regenerative medicine market in EMEA 2015-2020 ($ billions) Exhibit 46: Regenerative medicine market in APAC 2015-2020 ($ billions) Exhibit 47: Key developments in regenerative medicine market in Japan 2015 Exhibit 48: Global regenerative medicine market by geography 2015-2020 Exhibit 49: Global regenerative medicine market by geography 2015-2020 ($ billions) Exhibit 50: Breakdown of CIRM funding in various stem cell research studies 2014 ($ billions) Exhibit 51: Active programs under CIRM 2014 Exhibit 52: Funding by European Commission for regenerative medicine Exhibit 53: Impact of drivers Exhibit 54: Impact of drivers and challenges Exhibit 55: Major strategic alliances in global regenerative medicine market Exhibit 56: Mid- and late-stage pipeline products for regenerative medicine Exhibit 57: Clinical trials on gene therapy for various indications Exhibit 58: Vendors in global regenerative medicine market Exhibit 59: Acelity: Business segmentation by revenue 2015 Exhibit 60: Acelity: Regenerative medicine revenues and YoY growth rate 2013-2015 ($ millions) Exhibit 61: Acelity: Metrics analysis Exhibit 62: Medtronic: Metrics analysis Exhibit 63: MiMedx Group: Metrics analysis Exhibit 64: Organogenesis: Metrics analysis Exhibit 65: UniQure: Metrics analysis Exhibit 66: Zimmer Biomet: Metrics analysis Exhibit 67: Other prominent vendors

Acelity, Medtronic, MiMedx Group, Organogenesis, UniQure, ZimmerBiomet, ACE Surgical Supply, Acologix, Advanced Biologics, AlloCure, Allosource, Alphatec Spine, Altrika, Amorcyte, Anterogen, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Bellicum Pharmaceuticals, BioCardia, Biogen Idec, BioRestorative Therapies, Biostage, BioTissue Technologies, Bluebird Bio, BONESUPPORT, BrainStorm Cell Therapies, Caladrius Biosciences, Calimmune, Capricor Therapeutics, Celgene, Cell Medica, CellSeed, Cell Therapy, Celyad, CESCA THERAPEUTICS, CRC for Cell Therapy Manuracturing, Cryolife, Cynata Therapeutics, Cytori Therapeutics, Dendreon, DiscGenics, Fate Therapeutics, Fibrocell Science, Forticell Bioscience, Fortress Biotech, FUJIFILM, Gamida Cell, Geron, GlaxoSmithKline, Healthpoint, Histogen, Histogenics, Holostem Terapie Avanzate, Humacyte, ImmunoCellular Therapeutics, Integra LifeSciences, Intercytex, InVivo Therapeutics, iSTO Technologies, Janssen Pharma, Juno Therapeutics, Juventas Therapeutics, Kensey Nash, Kiadis Pharma, Kinetic Concept, LifeCell, LifeNet Health, Living Cell Technologies, Lonza, MaxCyte, MEDIPOST, Mesoblast, Nanofiber Solutions CTO, Nanotope, NeoStem, Neuralstem, Newlink Genetics, Northwest Biotherapeutics, NovaRx, Ocata, Opexa Therapeutics, Organovo Holdings, Orteg, Orthofix, Osiris Therapeutics, Osteotech, Pfizer, Pharmicell, Pluristem Therapeutics, PrimaBioMed, Q Therapeutics, Regenerex, Regenerys, Regience, Regrow, RepliCel, ReproCELL, Renova Therapeutics, RhinoCyte, Rohto Pharmaceutical, RTI Surgical, SanBio, Sangamo BioSciences, Shanghai Sunway Biotech, Shire Regenerative Medicine, StemCells, Stratatech, Takara Bio, TEI Biosciences, tella, Tengion, Tissue Genesis, TissueGene, Txcell, VentriNova, Vericel, ViaCyte, Vistagen.